Soubeyran Pierre
Soubeyran Pierre
Professeur d'Oncologie Médicale, Institut Bergonié, Université de Bordeaux
Adresse e-mail validée de
Citée par
Citée par
Follicular lymphoma international prognostic index
P Solal-Céligny, P Roy, P Colombat, J White, JO Armitage, R Arranz-Saez, ...
Blood 104 (5), 1258-1265, 2004
Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial
G Salles, JF Seymour, F Offner, A López-Guillermo, D Belada, L Xerri, ...
The Lancet 377 (9759), 42-51, 2011
Screening older cancer patients: first evaluation of the G-8 geriatric screening tool
CA Bellera, M Rainfray, S Mathoulin-Pélissier, C Mertens, F Delva, ...
Annals of Oncology 23 (8), 2166-2172, 2012
Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project
M Federico, M Bellei, L Marcheselli, S Luminari, A Lopez-Guillermo, ...
Journal of Clinical Oncology 27 (27), 4555-4562, 2009
Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study
P Soubeyran, C Bellera, J Goyard, D Heitz, H Curé, H Rousselot, ...
PloS one 9 (12), e115060, 2014
Phase III trial of consolidation therapy with yttrium-90–ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma
F Morschhauser, J Radford, A Van Hoof, U Vitolo, P Soubeyran, H Tilly, ...
Journal of Clinical Oncology 26 (32), 5156-5164, 2008
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update
C Bokemeyer, MS Aapro, A Courdi, J Foubert, H Link, A Österborg, ...
European Journal of Cancer 43 (2), 258-270, 2007
Predictors of early death risk in older patients treated with first-line chemotherapy for cancer
P Soubeyran, M Fonck, C Blanc-Bisson, JF Blanc, J Ceccaldi, C Mertens, ...
Journal of Clinical Oncology 30 (15), 1829-1834, 2012
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer
C Bokemeyer, MS Aapro, A Courdi, J Foubert, H Link, A Österborg, ...
European Journal of Cancer 40 (15), 2201-2216, 2004
High level of soluble programmed cell death ligand 1 in blood impacts overall survival in aggressive diffuse large B-Cell lymphoma: results from a French multicenter clinical trial
D Rossille, M Gressier, D Damotte, D Maucort-Boulch, C Pangault, ...
Leukemia 28 (12), 2367-2375, 2014
High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non–AIDS-related primary central nervous system lymphoma: European Organization for Research …
PMP Poortmans, HC Kluin-Nelemans, H Haaxma-Reiche, M Van’t Veer, ...
Journal of Clinical Oncology 21 (24), 4483-4488, 2003
Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research …
K Hoang-Xuan, L Taillandier, O Chinot, P Soubeyran, U Bogdhan, ...
Journal of Clinical Oncology 21 (14), 2726-2731, 2003
Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas
A Gonzalez-Aguilar, A Idbaih, B Boisselier, N Habbita, M Rossetto, ...
Clinical cancer research 18 (19), 5203-5211, 2012
Joint frailty models for recurring events and death using maximum penalized likelihood estimation: application on cancer events
V Rondeau, S Mathoulin-Pelissier, H Jacqmin-Gadda, V Brouste, ...
Biostatistics 8 (4), 708-721, 2007
Functional decline in older patients with cancer receiving first-line chemotherapy
S Hoppe, M Rainfray, M Fonck, L Hoppenreys, JF Blanc, J Ceccaldi, ...
Journal of Clinical Oncology 31 (31), 3877-3882, 2013
90Yttrium-Ibritumomab Tiuxetan Consolidation of First Remission in Advanced-Stage Follicular Non-Hodgkin Lymphoma: Updated Results After a Median Follow …
F Morschhauser, J Radford, A Van Hoof, B Botto, AZS Rohatiner, G Salles, ...
Journal of Clinical Oncology 31 (16), 1977-1983, 2013
EORTC Cancer in the Elderly Task Force guidelines for the use of colony-stimulating factors in elderly patients with cancer
L Repetto, L Biganzoli, CH Koehne, AS Luebbe, P Soubeyran, ...
European Journal of Cancer 39 (16), 2264-2272, 2003
IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas
N Gachard, M Parrens, I Soubeyran, B Petit, A Marfak, D Rizzo, M Devesa, ...
Leukemia 27 (1), 183-189, 2013
Radiotherapy or autologous stem-cell transplantation for primary CNS lymphoma in patients 60 years of age and younger: results of the intergroup ANOCEF-GOELAMS randomized phase …
C Houillier, L Taillandier, S Dureau, T Lamy, M Laadhari, O Chinot, ...
Journal of Clinical Oncology 37 (10), 823-833, 2019
Impact of [18F]Fluorodeoxyglucose Positron Emission Tomography Response Evaluation in Patients With High–Tumor Burden Follicular Lymphoma Treated With …
J Dupuis, A Berriolo-Riedinger, A Julian, P Brice, C Tychyj-Pinel, H Tilly, ...
Journal of clinical oncology 30 (35), 4317-4322, 2012
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20